Prevention of radial artery occlusion with rivaroxaban after trans-radial access coronary procedures: The RIVARAD multicentric randomized trial

Prevention of radial artery occlusion with rivaroxaban after trans-radial access coronary procedures: The RIVARAD multicentric randomized trial

BackgroundRadial artery occlusion (RAO) remains the most frequent complication of trans-radial access. Once the radial artery is occluded, its future use as an access site for coronary procedures, or as a conduit for coronary bypass grafting or fistula for hemodialysis, will be precluded. Therefore,...

Full description

Bibliographic Details
Main Authors: Rania Hammami, Slim Abid, Jdidi Jihen, Zied Triki, Imtinene Ben Mrad, Amine Kammoun, Mehdi Slim, Marwen Kacem, Houssem Thabet, Aymen Ben Abdessalem, Souad Mallek, Selma Charfeddine, Faten Triki, Samia Ernez Hejri, Ilyes Naffeti, Hicheme Denguir, Sondos Kraeim, Leila Abid
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
trans-radial access
radial artery occlusion
rivaroxaban
Doppler ultrasound
hemorrhagic complications
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1160459/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2023.1160459/full

Similar Items